Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14,265 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Close-to-lesion transbronchial biopsy: a novel technique to improve suitability of specimens for genetic testing in patients with peripheral pulmonary lesions.
Nishii Y, Sakaguchi T, Esumi S, Esumi M, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Yasui H, Ito A, Tarukawa T, Tsuruga T, D'Alessandro-Gabazza CN, Yasuma T, Fujimoto H, Asano F, Gabazza EC, Kobayashi T, Taguchi O, Hataji O. Nishii Y, et al. Among authors: nakamura y. Sci Rep. 2023 Sep 7;13(1):14724. doi: 10.1038/s41598-023-41726-w. Sci Rep. 2023. PMID: 37679360 Free PMC article.
Comparison of the analytical performance of the Oncomine dx target test focusing on bronchoscopic biopsy forceps size in non-small cell lung cancer.
Sakaguchi T, Nishii Y, Iketani A, Esumi S, Esumi M, Furuhashi K, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Katsuta K, Taguchi O, Hataji O. Sakaguchi T, et al. Among authors: nakamura y. Thorac Cancer. 2022 May;13(10):1449-1456. doi: 10.1111/1759-7714.14411. Epub 2022 Apr 5. Thorac Cancer. 2022. PMID: 35384314 Free PMC article.
Comparison of the analytical performance between the Oncomine Dx Target Test and a conventional single gene test for epidermal growth factor receptor mutation in non-small cell lung cancer.
Sakaguchi T, Iketani A, Furuhashi K, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Nishii Y, Katsuta K, Taguchi O, Hataji O. Sakaguchi T, et al. Among authors: nakamura y. Thorac Cancer. 2021 Feb;12(4):462-467. doi: 10.1111/1759-7714.13767. Epub 2020 Dec 12. Thorac Cancer. 2021. PMID: 33314600 Free PMC article.
Use of Ultrathin Bronchoscope on a Need Basis Improves Diagnostic Yield of Difficult-to-Approach Pulmonary Lesions.
Nishii Y, Nakamura Y, Fujiwara K, Ito K, Sakaguchi T, Suzuki Y, Furuhashi K, Kobayashi T, Yasuma T, D'Alessandro-Gabazza CN, Gabazza EC, Asano F, Taguchi O, Hataji O. Nishii Y, et al. Among authors: nakamura y. Front Med (Lausanne). 2020 Dec 15;7:588048. doi: 10.3389/fmed.2020.588048. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33385003 Free PMC article.
A method to improve genetic analysis of lung cancer samples.
Sakaguchi T, Iketani A, Furuhashi K, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Nishii Y, Katsuta K, Taguchi O, Hataji O. Sakaguchi T, et al. Among authors: nakamura y. Respirology. 2021 Sep;26(9):887-890. doi: 10.1111/resp.14114. Epub 2021 Jul 11. Respirology. 2021. PMID: 34250716 Free PMC article. No abstract available.
The Potential of Digital Polymerase Chain Reaction for Improving Diagnostic Yield of Nontuberculous Mycobacteria Pulmonary Disease.
Nishii Y, Furuhashi K, Nakamura S, Nishio M, Nakamura Y, Ushiro K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D'Alessandro-Gabazza C, Gabazza EC, Taguchi O, Hataji O. Nishii Y, et al. Among authors: nakamura y, nakamura s. Infect Drug Resist. 2021 Dec 1;14:5079-5087. doi: 10.2147/IDR.S338165. eCollection 2021. Infect Drug Resist. 2021. PMID: 34880633 Free PMC article.
An Extensive-stage Small-cell Lung Cancer Case With Preexisting Lambert-Eaton Myasthenic Syndrome Successfully Treated With an Immune Checkpoint Inhibitor.
Sakaguchi T, Kokubo Y, Furuhashi K, Nakamura Y, Suzuki Y, Ito K, Fujiwara K, Nishii Y, Taguchi O, Hataji O. Sakaguchi T, et al. Among authors: nakamura y. Clin Lung Cancer. 2022 May;23(3):e273-e275. doi: 10.1016/j.cllc.2021.09.001. Epub 2021 Sep 17. Clin Lung Cancer. 2022. PMID: 34642096 Free article. No abstract available.
Multicenter, single-blind, randomized controlled study of the efficacy and safety of favipiravir and nafamostat mesilate in patients with COVID-19 pneumonia.
Ikeda M, Okugawa S, Kashiwabara K, Moritoyo T, Kanno Y, Jubishi D, Hashimoto H, Okamoto K, Tsushima K, Uchida Y, Mitsumura T, Igari H, Tsutsumi T, Araoka H, Yatera K, Yamamoto Y, Nakamura Y, Otani A, Yamashita M, Wakimoto Y, Shinohara T, Adachi-Katayama M, Oyabu T, Kanematsu A, Harada S, Takeshita Y, Nakano Y, Miyazaki Y, Sakao S, Saito M, Ogura S, Yamasaki K, Kawasuji H, Hataji O, Inoue JI, Seto Y, Moriya K. Ikeda M, et al. Among authors: nakamura y. Int J Infect Dis. 2023 Mar;128:355-363. doi: 10.1016/j.ijid.2022.12.039. Epub 2023 Jan 4. Int J Infect Dis. 2023. PMID: 36610659 Free PMC article. Clinical Trial.
14,265 results
You have reached the last available page of results. Please see the User Guide for more information.